Kwivik Therapeutics Inc

About:

Novel Respiratory Devices to Disrupt Asthma, Emergency and Therapeutics Markets

Website: https://kwivikmedical.com

Twitter/X: kwivik_medical

Description:

Kwivik Therapeutics Inc. is a pre-IPO medtech leader that has developed a novel way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of novel products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding a remarkable $750 Billion.

Total Funding Amount:

$50M

Headquarters Location:

Frisco, Texas, United States

Founded Date:

2016-07-21

Contact Email:

kwivik(AT)kwivikmedical.com

Founders:

Julian Ross

Number of Employees:

11-50

Last Funding Date:

2018-10-01

IPO Status:

Private

© 2024 MyAiNote.com